PEMBROLIZUMAB

Overview

PEMBROLIZUMAB is a Schedule H drug.
Pembrolizumab is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Pembrolizumab is used to treat advanced skin cancer (melanoma); a certain type of non-small cell lung cancer, if your tumor tests positive for "PD-L1"; head and neck cancer; classical Hodgkin lymphoma in adults and children; a certain type of bladder and urinary tract cancer; a type of cancer that laboratory testing proves to be a microsatellite instability-high or a mismatch repair deficiency solid tumor; a certain type of cervical cancer if your tumor tests positive for "PD-L1"; advanced stomach cancer if your tumor tests positive for "PD-L1" and has a specific genetic marker (an abnormal "HER2/neu" gene).

Usage

PEMBROLIZUMAB is generally used to treat: Skin Cancer, Non-Small Cell Lung Cancer, Head Cancer, Neck Cancer, Hodgkin’s Disease, Cervical Cancer, Stomach Cancer

Frequently Asked Questions

Q: Is it safe on my liver?
A: Not Safe

Q: Is it safe on my kidney?
A: Not Safe

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Studies indicate Risk – Doctor advice is must

How Do I Take It?

Route of Administration: IV (Intravenous)

Precautions

People who receive a donor stem cell transplant after treatment with pembrolizumab may have very serious (possibly fatal) complications. This drug may make you dizzy. Alcohol or marijuana can make you more dizzy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages. Talk to your doctor if you are using marijuana. This medication is not recommended for use during pregnancy. It may harm an unborn baby. It is important to prevent pregnancy while receiving this medication and for 4 months after treatment. Consult your doctor for more details and to discuss the use of reliable forms of birth control (such as condoms, birth control pills) while receiving this medication and for 4 months after treatment. If you become pregnant or think you may be pregnant, tell your doctor right away.

Common Side-Effects

PEMBROLIZUMAB : Fatigue (tiredness), Ankles Swelling, Difficulty Sleeping

Serious Side-Effects

PEMBROLIZUMAB : Cough, Shortness Of Breath, Abdomen Pain, Eyes Yellow Eyes, Loss Of Appetite, Vomit, Head Headache, Dizziness, Fainting, Eyes Redness, Fever, Throat Soreness, Frequent Urination, Easy Bruising, Seizures (uncontrollable Jerking Of Limbs)

Rare Side-Effects

PEMBROLIZUMAB : Skin Rash, Body Itching, Face Swelling

Disease Interactions

PEMBROLIZUMAB can interfere with: Bacterial Infection, Fungal Infection, Protozoal Infection, Viral Inection, Primary Pulmonary Hypertension, Angioedema, Urticaria, Hypotension, Hypertension, Tumor Lysis Syndrome, Inflammatory Bowel Disease, Diabetes Mellitus, Acute Liver Failure, Multiple Myeloma, Acute Renal Failure

Technical Classification

PEMBROLIZUMAB is categorized as: ANTI-PD-1 MONOCLONAL ANTIBODIES / ANTINEOPLASTICS

Storage Conditions

Room Temperature (Between 15 To 25 C)

Available Alternatives

What are the other drugs with similar Ingredients?

PEMBROLIZUMAB

PEMBROLIZUMAB